Abstract
ObjectivesTofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). To further assess the potential role of Janus kinase inhibition in the development of malignancies, we...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have